Alcon Prices US$1.3 Billion Senior Notes Offering
November 29 2022 - 08:30PM
Business Wire
Alcon Inc. ("Alcon") (SIX/NYSE: ALC) announced that it has
commenced and priced a private offering of US$700 million aggregate
principal amount of its 5.375% senior notes due 2032 and US$600
million aggregate principal amount of its 5.750% senior notes due
2052 (together, the “Notes”). The Notes will be issued by Alcon
Finance Corporation, Alcon’s indirect subsidiary, and will be fully
and unconditionally guaranteed on a senior basis by Alcon.
The offering is expected to close on December 6, 2022, subject
to customary closing conditions.
Alcon intends to use the proceeds from the offering for general
corporate purposes, including the repayment of all outstanding
indebtedness under the bridge facility entered into in connection
with its acquisition of Aerie Pharmaceuticals, Inc., and to repay
all or part of the outstanding indebtedness under its term loan
facility.
Disclaimer
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: “anticipate,”
“intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,”
“seek,” “believe,” “project,” “estimate,” “expect,” “strategy,”
“future,” “likely,” “may,” “should,” “will” and similar references
to future periods.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
Alcon’s current beliefs, expectations and assumptions regarding the
future of Alcon’s business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
Alcon’s filings with the United States Securities and Exchange
Commission, including Alcon’s Annual Report on Form 20-F. Should
one or more of these uncertainties or risks materialize, or should
underlying assumptions prove incorrect, actual results may vary
materially from those anticipated. Therefore, you should not rely
on any of these forward-looking statements.
Alcon assumes no obligation to update forward-looking statements
as a result of new information, future events or otherwise.
This press release shall not constitute an offer to sell, or the
solicitation of an offer to buy, any securities, nor shall there be
any sales of securities mentioned in this press release in any
jurisdiction in which such offer, solicitation or sale would be
unlawful. Any offers of the Notes will be made only by means of a
private offering memorandum to qualified institutional buyers under
Rule 144A under the Securities Act of 1933, as amended (the
“Securities Act”) and to non-U.S. persons outside of the United
States under Regulation S under the Securities Act.
The Notes have not been registered under the Securities Act or
the securities laws of any other jurisdiction and may not be
offered or sold in the United States absent registration or an
applicable exemption from registration requirements.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning over 75 years, we offer the broadest
portfolio of products to enhance sight and improve people’s lives.
Our Surgical and Vision Care products touch the lives of more than
260 million people in over 140 countries each year living with
conditions like cataracts, glaucoma, retinal diseases and
refractive errors. Our more than 24,000 associates are enhancing
the quality of life through innovative products, partnerships with
Eye Care Professionals and programs that advance access to quality
eye care.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221129006128/en/
Investor Relations Dan
Cravens and Allen Trang + 41 589 112 110 (Geneva) + 1 817 615 2789
(Fort Worth) investor.relations@alcon.com
Media Relations Steven Smith
+ 41 589 112 111 (Geneva) + 1 817 551 8057 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Mar 2023 to Mar 2024